Oral peanut treatment trial for people with peanut allergy
Part of Immune system & allergy clinical trials.
This trial tests an oral (by mouth) immune treatment for people with confirmed peanut allergy. It aims to see whether your immune system can become less reactive to peanuts over time, while keeping you safe during testing with careful emergency planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed peanut allergy from test results (peanut blood IgE and/or a positive skin prick test).
- You must have had allergy symptoms shortly after eating peanuts (within 60 minutes).
- You need a positive supervised peanut challenge test at a low total dose (less than 10 grams).
- You must carry and be trained to use an epinephrine auto-injector at home.
- If you can become pregnant, you must use reliable birth control during the study and for 1 month after.
- You must be willing and able to pause certain allergy medicines before skin tests and challenge tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new peanut allergy treatment called ENP-501. It aims to see if the medicine can safely help people with peanut allergy become less sensitive to peanuts.
This early-phase study tests VE416, a treatment meant to help reduce peanut allergy reactions by changing how the immune system responds. If you have documented peanut allergy, you may receive the study medicine and, for some people, take part in a supervised peanut “entry challenge.”
This trial tests a new immunotherapy called UKK-0018 to treat peanut allergies in adults. The goal is to help your body become less sensitive to peanuts over time.
This trial tests whether adding tezepelumab (a biologic drug) to peanut oral immunotherapy can help people with peanut allergy better tolerate small amounts of peanut protein without having an allergic reaction.
This Phase 2 study tests whether taking capsules made from donor gut microbes is safe and can reduce allergic reactions to peanuts. It involves peanut allergy testing and close follow-up with stool samples and check-ins.
This study compares two types of peanut oral immunotherapy (a treatment that helps you build tolerance to peanuts) — one with standard peanuts and one with autoclaved (specially heat-treated) peanuts. It is for people with peanut allergy and aims to see which approach is safer and more effective.
Hear when a new Peanut Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.